Iván Galván‐Femenía

3.6k total citations
17 papers, 208 citations indexed

About

Iván Galván‐Femenía is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Iván Galván‐Femenía has authored 17 papers receiving a total of 208 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Genetics and 4 papers in Epidemiology. Recurrent topics in Iván Galván‐Femenía's work include Genetic Associations and Epidemiology (7 papers), RNA regulation and disease (2 papers) and Epigenetics and DNA Methylation (2 papers). Iván Galván‐Femenía is often cited by papers focused on Genetic Associations and Epidemiology (7 papers), RNA regulation and disease (2 papers) and Epigenetics and DNA Methylation (2 papers). Iván Galván‐Femenía collaborates with scholars based in Spain, United States and Papua New Guinea. Iván Galván‐Femenía's co-authors include Rafael de Cid, Andrés Aguilera, Lauro Sumoy, Emilia Herrera‐Moyano, Anna Carreras, Vı́ctor Moreno, Aleix Bayona‐Feliú, Mireia Obón‐Santacana, L. Puig and Juan Velasco and has published in prestigious journals such as New England Journal of Medicine, Nucleic Acids Research and Nature Communications.

In The Last Decade

Iván Galván‐Femenía

17 papers receiving 207 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iván Galván‐Femenía Spain 9 99 52 37 18 17 17 208
Paul Choppa United States 9 94 0.9× 16 0.3× 28 0.8× 38 2.1× 21 1.2× 13 281
Ana I. Hernández Cordero Canada 9 97 1.0× 62 1.2× 32 0.9× 12 0.7× 7 0.4× 22 243
Erica Sermijn Belgium 10 137 1.4× 146 2.8× 28 0.8× 10 0.6× 42 2.5× 18 332
Olivier B. Bakker Netherlands 6 93 0.9× 82 1.6× 20 0.5× 60 3.3× 10 0.6× 8 212
Marilynn Chan United States 7 173 1.7× 70 1.3× 19 0.5× 21 1.2× 25 1.5× 12 266
Teena Koshy India 9 74 0.7× 61 1.2× 19 0.5× 29 1.6× 41 2.4× 41 250
Sergio Villicaña United Kingdom 6 133 1.3× 57 1.1× 21 0.6× 25 1.4× 23 1.4× 10 229
Miquel Vázquez-Santiago Spain 5 37 0.4× 49 0.9× 16 0.4× 24 1.3× 4 0.2× 7 173
Ran Gao China 8 255 2.6× 54 1.0× 15 0.4× 21 1.2× 73 4.3× 33 341
Yingming Zheng China 8 69 0.7× 43 0.8× 9 0.2× 27 1.5× 10 0.6× 18 286

Countries citing papers authored by Iván Galván‐Femenía

Since Specialization
Citations

This map shows the geographic impact of Iván Galván‐Femenía's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iván Galván‐Femenía with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iván Galván‐Femenía more than expected).

Fields of papers citing papers by Iván Galván‐Femenía

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iván Galván‐Femenía. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iván Galván‐Femenía. The network helps show where Iván Galván‐Femenía may publish in the future.

Co-authorship network of co-authors of Iván Galván‐Femenía

This figure shows the co-authorship network connecting the top 25 collaborators of Iván Galván‐Femenía. A scholar is included among the top collaborators of Iván Galván‐Femenía based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iván Galván‐Femenía. Iván Galván‐Femenía is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Carreras‐Torres, Robert, Iván Galván‐Femenía, Xavier Farré, et al.. (2024). Multiomic integration analysis identifies atherogenic metabolites mediating between novel immune genes and cardiovascular risk. Genome Medicine. 16(1). 2 indexed citations
2.
Díez-Villanueva, Anna, Berta Martín, Ferrán Moratalla-Navarro, et al.. (2023). Identification of intergenerational epigenetic inheritance by whole genome DNA methylation analysis in trios. Scientific Reports. 13(1). 21266–21266. 5 indexed citations
3.
Bayona‐Feliú, Aleix, et al.. (2023). The chromatin network helps prevent cancer-associated mutagenesis at transcription-replication conflicts. Nature Communications. 14(1). 6890–6890. 28 indexed citations
4.
González-Beiras, Camila, Wendy Houinei, Petra Pospíšilová, et al.. (2022). Trial of Three Rounds of Mass Azithromycin Administration for Yaws Eradication. New England Journal of Medicine. 386(1). 47–56. 13 indexed citations
5.
Galván‐Femenía, Iván, Juan Luís Becerra, Isabel Bielsa, et al.. (2021). Revisiting the UK Genetic Severity Score for NF2: a proposal for the addition of a functional genetic component. Journal of Medical Genetics. 59(7). 678–686. 7 indexed citations
6.
Galván‐Femenía, Iván, C. Barceló‐Vidal, Lauro Sumoy, et al.. (2021). A likelihood ratio approach for identifying three-quarter siblings in genetic databases. Heredity. 126(3). 537–547. 4 indexed citations
7.
Blay, Natàlia, Eduard Casas, Iván Galván‐Femenía, et al.. (2019). Assessment of kinship detection using RNA-seq data. Nucleic Acids Research. 47(21). e136–e136. 6 indexed citations
8.
Graffelman, Jan, et al.. (2019). A Log-Ratio Biplot Approach for Exploring Genetic Relatedness Based on Identity by State. Frontiers in Genetics. 10. 341–341. 2 indexed citations
9.
Pujantell, Maria, Roger Badía, Iván Galván‐Femenía, et al.. (2019). ADAR1 function affects HPV replication and is associated to recurrent human papillomavirus-induced dysplasia in HIV coinfected individuals. Scientific Reports. 9(1). 19848–19848. 10 indexed citations
10.
Obón‐Santacana, Mireia, Mireia Vilardell, Anna Carreras, et al.. (2018). GCAT|Genomes for life: a prospective cohort study of the genomes of Catalonia. BMJ Open. 8(3). e018324–e018324. 31 indexed citations
11.
Roso‐Llorach, Albert, Luís Palomero, Daniel Cuadras, et al.. (2018). Disease networks identify specific conditions and pleiotropy influencing multimorbidity in the general population. Scientific Reports. 8(1). 15970–15970. 21 indexed citations
12.
Pujantell, Maria, Sandra Franco, Iván Galván‐Femenía, et al.. (2018). ADAR1 affects HCV infection by modulating innate immune response. Antiviral Research. 156. 116–127. 28 indexed citations
13.
Galván‐Femenía, Iván, Mireia Obón‐Santacana, David Piñeyro, et al.. (2018). Multitrait genome association analysis identifies new susceptibility genes for human anthropometric variation in the GCAT cohort. Journal of Medical Genetics. 55(11). 765–778. 24 indexed citations
14.
Galván‐Femenía, Iván, et al.. (2018). Pipeline design to identify key features and classify the chemotherapy response on lung cancer patients using large-scale genetic data. BMC Systems Biology. 12(S5). 97–97. 6 indexed citations
15.
Galván‐Femenía, Iván, Marta Guindo-Martínez, Silvia Calabuig‐Fariñas, et al.. (2018). Genomic profiling in advanced stage non-small-cell lung cancer patients with platinum-based chemotherapy identifies germline variants with prognostic value in SMYD2. Cancer Treatment and Research Communications. 15. 21–31. 9 indexed citations
16.
Galván‐Femenía, Iván, et al.. (2017). Graphics for relatedness research. Molecular Ecology Resources. 17(6). 1271–1282. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026